SP
Salarius Pharmaceuticals Inc
🇺🇸XNAS.SLRXUnited StatesHealthcare
$0.84USDup +0.19 (+29.23%)OpenDelayed3:25 PM
Price$0.84+0.19 (+29.23%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US79400X4043
- CUSIP
- 79400X107
Company
- Employees
- 2
- Headquarters
- Houston, United States
- CEO
- Mr. Frederick E. Pierce II
Market
- Shares outstanding
- 5.9M
- Market cap
- $4.92M
Highlights
- Market cap
- $4.92M
- EPS LTM
- -$0.85calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.98calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.43K-75.26%down year on year
- Net income
- -$5M-0.22%down year on year
- Gross margin
- -24.97%-133.16%down year on year
- Free cash flow
- -$4.43M+16.26%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.